Resonance Health LtdASX: RHT

Investor Presentation Liver Fibrosis Device & Capital Raise

· Issued by Resonance Health Ltd via ASX

Filed with ASX ·

NON-INVASIVE MRI LIVER FIBROSIS DEVICE PRELIMINARY EPOC STUDY RESULTS & CAPITAL RAISING PRESENTATION | OCTOBER 2026 Funding three growth programmes from a profitable, cash-generative base Andrew Harrison | MD & CEO Benjamin Carruthers | CFO Resonance Health Ltd (ASX:RHT) CONFIDENTIAL - NOT FOR...

View Attachment

6ix is reading this filing.

Resonance Health Ltd on 6ix

In the deck

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases